Nanosphere's Q1 Revenues, Loss Rise | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere today reported that its first-quarter 2010 revenues more than tripled year over year but were flat sequentially.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $825,827 for the three months ended March 31, compared to $255,225 for the first quarter of 2009. However, its revenues were flat from Q4 2009. Analysts, on average, had expected revenues of $1.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.